EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Interindividual Sleep Variability Across the Psychosis Spectrum

Rosario Aronica, John Torous, Amedeo Minichino, Melinda Mills, Philip McGuire, Dominic Oliver

JAMA Network Open · 22.07.2026 · 9 (7) · e2624358

DOI: 10.1001/jamanetworkopen.2026.24358 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift JAMA Network Open, online erschienen am 22.07.2026. Verfasst von Rosario Aronica und 5 weiteren Autor:innen. Beteiligte Einrichtung: Warneford Hospital, Oxford Health NHS Foundation Trust, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Psychotic Disorders, Sleep Wake Disorders, Sleep, Schizophrenia. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Sleep disturbances are common across the psychosis spectrum and may precede overt core clinical symptoms. Most studies focus on mean differences and overlook interindividual variability, which can be informative for stratified care.

Objective

To quantify interindividual variability in actigraphy sleep measures across psychosis stages among individuals at clinical high risk for psychosis (CHR-P) and those with schizophrenia spectrum disorders (SSDs) compared with healthy control participants. Data Sources The PubMed, Embase, MEDLINE, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, EU Clinical Trials Register, World Health Organization International Clinical Trials Registry Platform, and OpenGrey databases were searched for studies published from inception to April 29, 2024. An updated search was performed to identify studies published between April 30, 2024, and April 25, 2026. Study Selection Case-control studies using wrist actigraphy in participants at CHR-P or with SSDs compared with healthy control participants were selected. Data Extraction and Synthesis This systematic review and meta-analysis was preregistered with the Center for Open Science and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Data were independently extracted under PRISMA standards. Two reviewers independently applied the inclusion criteria. Main Outcomes and Measures The primary outcome was the natural logarithm of the variability ratio (lnVR) for total sleep time (TST). Secondary outcomes were the lnVR and the natural logarithm of the coefficient of variation ratio (lnCVR) for all actigraphy sleep parameters, including time in bed (TIB), sleep latency, wake after sleep onset (WASO), sleep efficiency, and number of awakenings. Variability metrics (lnVR and lnCVR) were pooled using random-effects models. Heterogeneity was assessed with Q , I 2 , and τ 2 values and 95% CIs. Univariable mixed-effects meta-regression analysis tested antipsychotic use, with age and sex as moderators of the primary outcome. Each key result was tested against a panel of sensitivity analyses.

Results

Of the 19 studies that met criteria, 18 entered the quantitative synthesis (1 study reported outcomes as medians and was excluded). Eighteen studies (n = 1358), including 202 individuals at CHR-P (mean [SD] age, 20.7 [2.8] years; 104 female [51.4%]), 574 individuals with SSDs (mean [SD] age, 37.7 [10.2] years; 363 female [63.2%]), and 582 healthy control participants (mean [SD] age, 31.5 [8.6] years; 311 male [53.4%]), were meta-analyzed. Participants at CHR-P had greater variability in TIB (lnVR, 0.29 [95% CI, 0.04-0.54] minutes; I 2 = 0%; P = .02), WASO (0.45 [95% CI, 0.07-0.83] minutes; I 2 = 83%; P = .02), and sleep efficiency (0.35% [95% CI, 0.06%-0.64%]; I 2 = 72%; P = .02). Participants with SSDs had greater variability in TST (0.46 [95% CI, 0.28-0.64] minutes; I 2 = 70%; P < .001), TIB (0.38 [95% CI, 0.19-0.56] minutes; I 2 = 0%; P < .001), WASO (0.52 [95% CI, 0.15-0.89] minutes; I 2 = 88%; P = .006), and sleep efficiency (0.27% [95% CI, 0.04%-0.50%]; I 2 = 71%; P = .02). Moderator effects were nonsignificant. Conclusions and Relevance In this systematic review and meta-analysis of 18 case-control studies, distinct digital phenotypes of sleep variability were identified among individuals across the psychosis spectrum compared with healthy control participants. These findings support further investigations of sleep as a candidate biomarker to inform stratified care in psychosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotic DisordersSleep Wake DisordersSleepSchizophreniaHumansActigraphyFemaleMaleSleep DurationCase-Control StudiesAdult

Autor:innen und Institutionen

  • Warneford Hospital, Oxford Health NHS Foundation Trust, Oxford, United Kingdom.
  • Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
  • Leverhulme Centre for Demographic Science, University of Oxford, Oxford, United Kingdom.

Zitieren

APA

Aronica, R., Torous, J., Minichino, A., Mills, M., McGuire, P., & Oliver, D. (2026). Interindividual Sleep Variability Across the Psychosis Spectrum. JAMA Network Open, 9(7), e2624358. https://doi.org/10.1001/jamanetworkopen.2026.24358

Vancouver

Aronica R, Torous J, Minichino A, Mills M, McGuire P, Oliver D. Interindividual Sleep Variability Across the Psychosis Spectrum. JAMA Network Open. 2026;9(7):e2624358. doi:10.1001/jamanetworkopen.2026.24358

BibTeX
@article{Aronica2026,
  author = {Aronica, Rosario and Torous, John and Minichino, Amedeo and Mills, Melinda and McGuire, Philip and Oliver, Dominic},
  title = {Interindividual Sleep Variability Across the Psychosis Spectrum},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2624358},
  doi = {10.1001/jamanetworkopen.2026.24358}
}
Kostenlos starten →